In addition to changes in tumor cell morphology, the process of EMT is also accompanied by changes in related molecular markers, such as the downregulation and expression of epithelial cell markers such as E-cadherin or ZO-1, and upregulation of the expression of mesenchymal cell phenotypic markers such as vimentin and N-cadherin [30]. The gene discussed is CDH2; the disease is neoplasm.